Back

An Efficacy and Safety Study of Palovarotene for the Treatment of MO

- 22 January 2025 - 1 mins read

This is a randomized, double-blind, placebo-controlled study comparing the safety and efficacy of 2 dosage regimens of palovarotene versus placebo in preventing disease progression in pediatric subjects with multiple osteochondromas (MO).

Related Clinical Trials

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis – Study 1
22 January 2025 1 mins read

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis – Study 1
Effects of triptorelin when given every 6-months under the skin to adult males with cancer in the prostate
22 January 2025 1 mins read

Effects of triptorelin when given every 6-months under the skin to adult males with cancer in the prostate
Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly
22 January 2025 1 mins read

Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines
22 January 2025 1 mins read

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines
A Study to Assess the Safety and Efficacy of IPN10200 of in Adult Participants With Upper Limb Spasticity.
22 January 2025 1 mins read

A Study to Assess the Safety and Efficacy of IPN10200 of in Adult Participants With Upper Limb Spasticity.
Study to evaluate the safety and activity (including distribution) of 177Lu-3BP-227 in subjects with solid tumours expressing neurotensin receptor type 1.
22 January 2025 1 mins read

Study to evaluate the safety and activity (including distribution) of 177Lu-3BP-227 in subjects with solid tumours expressing neurotensin receptor type 1.
A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
22 January 2025 1 mins read

A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2)
22 January 2025 1 mins read

Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic...
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs
22 January 2025 1 mins read

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs
Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer
22 January 2025 1 mins read

Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer